GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 05:45:00 2026-07-21 am EDT			5-day change	1st Jan Change
1,883.00 ^GBX	+0.05%		-1.81%	+3.36%

01:10am	Novartis beats forecasts with $6 billion profit as it navigates expiring patents	RE
Jul. 20	Gsk plc Receives European Medicines Agency Acceptance for Submission to Update Bexsero Label for 1-Dose Meningitis B Booster in Individuals Aged 10 Years and Older	CI

GSK : Jefferies remains its Buy rating

Published on 06/03/2026 at 04:39 pm EDT

MarketScreener with dpa-AFX Analyser

Add MarketScreener to your sources

GSK PLC

+0.08%

In a research note published by Michael Leuchten, Jefferies advises its customers to buy the stock. The target price continues to be set at GBX 2500.

Add MarketScreener to your sources

Latest news about GSK plc

01:10am	Novartis beats forecasts with $6 billion profit as it navigates expiring patents	RE
Jul. 20	Gsk plc Receives European Medicines Agency Acceptance for Submission to Update Bexsero Label for 1-Dose Meningitis B Booster in Individuals Aged 10 Years and Older	CI
Jul. 20	GSK : Deutsche Bank remains Neutral	ZD
Jul. 20	GSK secures European review for meningitis vaccine booster	AN
Jul. 20	ProLogis announces fresh bid for Segro	AN
Jul. 20	European Medicines Agency Accepts GSK's Label Expansion Request for Meningococcal Disease Vaccine	MT
Jul. 20	GSK Wins European Label Expansion for Meningococcal Disease Vaccine	MT
Jul. 17	UK's FTSE 100 rises on utilities, energy boost; Burnham becomes Labour Party leader	RE
Jul. 17	European Equities Traded in the US as American Depositary Receipts Decline Friday	MT
Jul. 17	Global markets live: Netflix, Coca-Cola, Apple, Google, SpaceX…
Jul. 17	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investors Retreat From Chipmaker Stocks	MT
Jul. 17	GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment	DJ
Jul. 17	GSK : Jefferies reiterates its Buy rating	ZD
Jul. 17	GSK : JP Morgan maintains a Sell rating	ZD
Jul. 17	FTSE 100 bucks European AI stock selloff	AN

GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).

Employees

66,841

Sector

Pharmaceuticals

Calendar

Jul. 28 - Earnings release - Q2 2026

More about the company